Hypoxia signaling during intestinal ischemia and inflammation

Current Opinion in Critical Care

Volumn 18, Issue 2, 2012, Pages 178-185

  Grenz, Almut ^a   Clambey, Eric ^a   Eltzschig, Holger K ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

A2BAR; adenosine receptor; HIF; hypoxia inducible factor; netrin 1; PHD; prolyl hydroxylase

Indexed keywords

ADENOSINE; ADENOSINE A2 RECEPTOR; HYPOXIA INDUCIBLE FACTOR; NETRIN 1;

CRITICAL ILLNESS; DIGESTIVE SYSTEM INJURY; ENTERITIS; GENE EXPRESSION; HUMAN; HYPOXIA; INTESTINE ISCHEMIA; MULTIPLE ORGAN FAILURE; NONHUMAN; REVIEW;

ANIMALS; CRITICAL ILLNESS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; INTESTINAL DISEASES; INTESTINES; ISCHEMIA; MICE; RECEPTOR, ADENOSINE A2B; SIGNAL TRANSDUCTION;

EID: 84858797646     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283514bd0     Document Type: Review

References (72)

1. Colgan SP, Eltzschig HK. Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. Annu Rev Physiol 2012; 74:7.1-7.23.
2. Eltzschig HK. Adenosine: an old drug newly discovered. Anesthesiology 2009; 111:904-915.
3. Eltzschig HK, Rivera-Nieves J, Colgan SP. Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation. Expert Opin Ther Targets 2009; 13:1267-1277.
4. Hartmann H, Eltzschig HK, Wurz H, et al. Hypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores. Gastroenterology 2008; 134:756-767.
5. Koeppen M, Eckle T, Eltzschig HK. The hypoxia-inflammation link and potential drug targets. Curr Opin Anaesthesiol 2011; 24:363-369.
6. Kong T, Westerman KA, Faigle M, et al. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J 2006; 20:2242-2250. (Pubitemid 44953854)
7. Kuhlicke J, Frick JS, Morote-Garcia JC, et al. Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS ONE 2007; 2:e1364.
8. Synnestvedt K, Furuta GT, Comerford KM, et al. Ecto-50-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 2002; 110:993-1002.
9. Zheng W, Kuhlicke J, Jackel K, et al. Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium. FASEB J 2009; 23:204-213.
10. Park SW, Kim M, Brown KM, et al. Paneth cell-derived IL-17A causes multiorgan dysfunction after hepatic ischemia and reperfusion injury. Hepatology 2011; 53:1662-1675.
11. Eckle T, Fullbier L, Grenz A, et al. Usefulness of pressure-controlled ventilation at high inspiratory pressures to induce acute lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2008; 295:L718-L724.
12. Eckle T, Fullbier L, Wehrmann M, et al. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 2007; 178:8127-8137. (Pubitemid 46898085)
13. Eckle T, Grenz A, Laucher S, et al. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest 2008; 118:3301-3315.
14. Eckle T, Koeppen M, Eltzschig HK. Role of extracellular adenosine in acute lung injury. Physiology (Bethesda) 2009; 24:298-306.
15. Colgan SP, Taylor CT. Hypoxia: an alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol 2010; 7:281-287.
16. Taylor CT. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J Physiol 2008; 586:4055-4059.
17. Taylor CT, Colgan SP. Hypoxia and gastrointestinal disease. J Mol Med 2007; 85:1295-1300. (Pubitemid 50004090)
18. Eltzschig HK, Eckle T. Ischemia and reperfusion: from mechanism to translation. Nat Med 2011; 17:1391-1401.
19. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011; 364:656-665.
20. Eckle T, Faigle M, Grenz A, et al. A2B adenosine receptor dampens hypoxiainduced vascular leak. Blood 2008; 111:2024-2035. (Pubitemid 351451513)
21. Eltzschig HK, Abdulla P, Hoffman E, et al. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 2005; 202:1493-1505. (Pubitemid 41746596)
22. Eltzschig HK, Eckle T, Mager A, et al. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res 2006; 99:1100-1108. (Pubitemid 44729934)
23. Eltzschig HK, Faigle M, Knapp S, et al. Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood 2006; 108:1602-1610. (Pubitemid 44316128)
24. Eltzschig HK, Ibla JC, Furuta GT, et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 2003; 198:783-796. (Pubitemid 37087777)
25. Eltzschig HK, Thompson LF, Karhausen J, et al. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 2004; 104:3986-3992. (Pubitemid 39620148)
26. Faigle M, Seessle J, Zug S, et al. ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PLoS ONE 2008; 3:e2801.
27. Schingnitz U, Hartmann K, Macmanus CF, et al. Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J Immunol 2010; 184:5271-5279.
28. Thompson LF, Eltzschig HK, Ibla JC, et al. Crucial role for ecto-50-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 2004; 200:1395-1405. (Pubitemid 39657287)
29. Colgan SP, Eltzschig HK, Eckle T, et al. Physiological roles of 50-ectonucleotidase (CD73). Purinergic Signal 2006; 2:351-360.
30. Frick JS, MacManus CF, Scully M, et al. Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J Immunol 2009; 182:4957-4964.
31. Eltzschig HK, Macmanus CF, Colgan SP. Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface. Trends Cardiovasc Med 2008; 18:103-107. (Pubitemid 351626607)
32. Eltzschig HK, Kohler D, Eckle T, et al. Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 2009; 113:224-232.
33. Eltzschig HK, Collard CD. Vascular ischaemia and reperfusion injury. Br Med Bull 2004; 70:71-86. (Pubitemid 40069373)
34. Hart ML, Kohler D, Eckle T, et al. Direct treatment of mouse or human blood with soluble 50-nucleotidase inhibits platelet aggregation. Arterioscler Thromb Vasc Biol 2008; 28:1477-1483.
35. Aherne CM, Kewley EM, Eltzschig HK. The resurgence of A2B adenosine receptor signaling. Biochim Biophys Acta 2011; 1808:1329-1339.
36. Bauerle JD, Grenz A, Kim JH, et al. Adenosine generation and signaling during acute kidney injury. J Am Soc Nephrol 2011; 22:14-20.
37. Koeppen M, Eckle T, Eltzschig HK. Interplay of hypoxia and A2B adenosine receptors in tissue protection. Adv Pharmacol 2011; 61:145-186.
38. Grenz A, Homann D, Eltzschig HK. Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia. Antioxid Redox Signal 2011; 15:2221-2234.
39. Aherne CM, Collins CB, Masterson JC, et al. Neuronal guidance molecule netrin-1 attenuates inflammatory cell trafficking during acute experimental colitis. Gut 2011. [Epub ahead of print]
40. Rosenberger P, Schwab JM, Mirakaj V, et al. Hypoxia-inducible factordependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 2009; 10:195-202.
41. Collins CB, Aherne CM, Kominsky D, et al. Retinoic acid attenuates ileitis by restoring the balance between T-helper 17 and T regulatory cells. Gastroenterology 2011; 141:1821-1831.
42. Collins CB, Aherne CM, McNamee EN, et al. Flt3 ligand expands CD103+ dendritic cells and FoxP3+ T regulatory cells, and attenuates Crohn's-like murine ileitis. Gut 2011. [Epub ahead of print]
43. Karhausen J, Haase VH, Colgan SP. Inflammatory hypoxia: role of hypoxiainducible factor. Cell Cycle 2005; 4.
44. Karhausen J, Furuta GT, Tomaszewski JE, et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 2004; 114:1098-1106. (Pubitemid 39578699)
45. Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008; 30:393-402. (Pubitemid 351681994)
46. Kaelin WG. Proline hydroxylation and gene expression. Annu Rev Biochem 2005; 74:115-128.
47. Kaelin WG. Von Hippel-Lindau disease. Annu Rev Pathol 2007; 2:145-173.
48. Mahon PC, Hirota K, Semenza GL. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 2001; 15:2675-2686. (Pubitemid 32988878)
49. Fraisl P, Aragones J, Carmeliet P. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat Rev Drug Discov 2009; 8:139-152.
50. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005; 2005:re12.
51. Semenza GL. Life with oxygen. Science 2007; 318:62-64. (Pubitemid 47538005)
52. Narravula S, Colgan SP. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. J Immunol 2001; 166:7543-7548. (Pubitemid 32525634)
53. Morote-Garcia JC, Rosenberger P, Kuhlicke J, et al. HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 2008; 111:5571-5580.
54. Morote-Garcia JC, Rosenberger P, Nivillac NM, et al. Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia. Gastroenterology 2009; 136:607-618.
55. Semenza GL, Roth PH, Fang HM, et al. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994; 269:23757-23763. (Pubitemid 24293585)
56. Fukuda R, Zhang H, Kim JW, et al. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007; 129:111-122. (Pubitemid 46507584)
57. Carmeliet P, Baes M. Metabolism and therapeutic angiogenesis. N Engl J Med 2008; 358:2511-2512.
58. Wang G, Jiang B, Rue E, et al. Hypoxia-inducible factor 1 is a basic-helix-loophelix-PAS heterodimer regulated by cellular O2 tension. PNAS 1995; 92:5510-5514.
59. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004; 5:343-354. (Pubitemid 38579472)
60. Aragones J, Fraisl P, Baes M, et al. Oxygen sensors at the crossroad of metabolism. Cell Metab 2009; 9:11-22.
61. Kaelin WGJr. The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer 2008; 8:865-873.
62. Riegel AK, Faigle M, Zug S, et al. Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation. Blood 2011; 117:2548-2555.
63. McDonald B, Pittman K, Menezes GB, et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010; 330:362-366.
64. Hart ML, Gorzolla IC, Schittenhelm J, et al. SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. J Immunol 2010; 184:4017-4024.
65. Friedman DJ, Kunzli BM, AR YI, et al. From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci U S A 2009; 106:16788-16793.
66. Guckelberger O, Sun XF, Sevigny J, et al. Beneficial effects of CD39/ectonucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury. Thromb Haemost 2004; 91:576-586. (Pubitemid 38396881)
67. Grenz A, Zhang H, Hermes M, et al. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J 2007; 21:2863-2873. (Pubitemid 47372753)
68. Kohler D, Eckle T, Faigle M, et al. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 2007; 116:1784-1794. (Pubitemid 350287103)
69. Reutershan J, Vollmer I, Stark S, et al. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J 2009; 23:473-482.
70. Pinsky DJ, Broekman MJ, Peschon JJ, et al. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest 2002; 109:1031-1040. (Pubitemid 34408578)
71. Eckle T, Krahn T, Grenz A, et al. Cardioprotection by ecto-50-nucleotidase (CD73) and A2B adenosine receptors. Circulation 2007; 115:1581-1590. (Pubitemid 46648643)
72. Grenz A, Zhang H, Eckle T, et al. Protective role of ecto-50-nucleotidase (CD73) in renal ischemia. J Am Soc Nephrol 2007; 18:833-845. (Pubitemid 46434500)